Xenon Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.About XENE
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.
CEOIan C. Mortimer
CEOIan C. Mortimer
Employees327
Employees327
HeadquartersBurnaby, British Columbia
HeadquartersBurnaby, British Columbia
Founded1996
Founded1996
Employees327
Employees327
XENE Key Statistics
Market cap2.98B
Market cap2.98B
Price-Earnings ratio-10.89
Price-Earnings ratio-10.89
Dividend yield—
Dividend yield—
Average volume696.85K
Average volume696.85K
High today$38.99
High today$38.99
Low today$38.09
Low today$38.09
Open price$38.57
Open price$38.57
Volume667.64K
Volume667.64K
52 Week high$46.00
52 Week high$46.00
52 Week low$26.74
52 Week low$26.74
XENE News
Simply Wall St 6d
Did Rising Losses in Q2 Shift Xenon Pharmaceuticals' Investment Narrative?Xenon Pharmaceuticals recently announced its second quarter and six-month 2025 earnings, reporting a net loss of US$84.71 million for the quarter and US$149.75...
Analyst ratings
100%
of 19 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own XENE. This list is generated using Robinhood data, and it’s not a recommendation.